Eve, Heather E <br/><br/>
Impairment of peripheral blood stem-cell mobilisation in patients with mantle-cell lymphoma following primary treatment with fludarabine and cyclophosphamide +/- rituximab.  [electronic resource] 

 -  Leukemia & lymphoma  Mar 2009 
 - 463-5 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study 
<br/><br/><label>ISSN: </label>1029-2403 
<br/><br/><label>Standard No.: </label>10.1080/10428190802641979  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antibodies, Monoclonal--therapeutic use<br/>Antibodies, Monoclonal, Murine-Derived<br/>Antigens, CD34<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Cell Count<br/>Cyclophosphamide--administration & dosage<br/>Female<br/>Hematopoietic Stem Cell Mobilization--methods<br/>Humans<br/>Lymphoma, Mantle-Cell--therapy<br/>Male<br/>Middle Aged<br/>Rituximab<br/>Vidarabine--administration & dosage